research Effect of platelet-rich plasma on diffuse efflffluvium in post-COVID-19 infection
PRP treatment helps reduce hair loss in post-COVID-19 patients.
Search
for
Sort by
Research
690-720 / 1000+ results
research The childbearing years: hair diseases
Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.
research Efficacy Assessment of a Nutraceutical with a Marine Protein Complex in the Reduction of Female Telogen EffluviumEfficacy Assessment of a Nutraceutical with a Marine Protein Complex in the Reduction of Female Telogen Effluvium
The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.
research Prospects for the use of physiotherapy methods in the treatment of telogen alopecia
Physiotherapy methods can effectively stimulate hair growth in telogen alopecia.
research Intradermoterapia com Plasma Rico em Plaquetas (PRP) no tratamento capilar: uma revisão
PRP is a safe and effective treatment for hair loss.
research To Demonstrate the Role of Iron, Vitamin B12, and Vitamin D in Young Females with Chronic Telogen Effluvium Attending the Tertiary Care Centre of Jharkhand
Low iron and vitamin D are common in young females with hair loss.
research FRI378 Estetrol Prolongs Anagen In Healthy Female Scalp Hair Follicles By Positively Modulating Dermal Papilla Functions And Generation Of Progenitor Stem Cells Ex Vivo
Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.
research Prevalence and factors associated with telogen effluvium in adult females at Makkah region, Saudi Arabia: A retrospective study
Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.
research Bitemporal alopecia: A unique pattern variant of alopecia
The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.
research A Hospital Based Cross Sectional Study Evaluating Haemoglobin, Iron Profile and Thyroid Function Tests in Women with Telogen Effluvium, Female Pattern Hair Loss, and Alopecia Areata
Iron profile tests are recommended for women with hair loss, as haemoglobin levels alone are not reliable.
research Efficacy of QR678 Neo® hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.
research Significant impact of telogen effluvium on quality of life, depression, anxiety and stress: a prospective case-control study
Telogen effluvium negatively affects quality of life, increasing stress, depression, and anxiety.
research Hair as a retrospective calendar of cortisol production—Increased cortisol incorporation into hair in the third trimester of pregnancy
Hair cortisol levels can show increased stress during late pregnancy but only for up to six months.
research Comparative analysis of various hair peptide serums in managing telogen effluvium in females: Efficacy, safety, and patient satisfaction
The cytokine and peptide serum was most effective in reducing hair loss and improving hair growth.
research The Impact of Pregnancy Specific Distress on Hair Loss in Women in Their Third Trimester
Pregnancy-related stress may cause hair loss in women in their third trimester.
research Alopecia From Oral Contraceptives
Oral contraceptives may cause hair loss in women.
research 459 Estetrol prevents catagen progression in healthy and female pattern hair loss hair follicles ex vivo
Estetrol may help prevent hair loss and support hair growth in women.
research Isolated eyebrow loss in frontal fibrosing alopecia: relevance of early diagnosis and treatment
research Estimation of Serum Ferritin Level in Female Patients with Telogen
Serum ferritin levels do not cause hair loss in women with telogen effluvium.
research Female pattern hair loss
Female pattern hair loss is common in women, treatable with medications, and can affect mental health.
research Alopecia fibrosante frontal
Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.
research Culprits of Medication-Induced Telogen Effluvium, Part 2
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
research 원저 / 탈모증환자 1505명의 임상적 연구
Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.
research Congenital alopecia areata
Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.
research Avaliação da efetividade do tratamento da alopecia androgenética masculina com finasteride, minoxidil tópico e associação de finasteride e monoxidil
research Postmenopausal Frontal Fibrosing Alopecia
Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.
research Chirurgia dermatologica estetica del cuoio capelluto
New techniques and treatments can effectively and safely increase hair density for everyone.
research Pubic to Scalp F.U.E. Hair Transplant for Transgender
A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.
research Diffuse hair loss: Its triggers and management
To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.